Exosome Diagnostics and Therapeutics: Global Markets

Dec 2021| BIO149D| BCC Publishing
Report Overview

Report Highlights

The global market for exosome diagnostics and therapeutics should grow from $97.8 million in 2021 to $512.6 million by 2026, at compound annual growth rate (CAGR) of 39.3% for the period of 2021-2026.

Report Includes

  • 109 tables
  • An updated review of the global market for exosome diagnostics and therapeutics within the biotech research industry
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Estimation and forecast the overall global market size, and corresponding market share analysis by application, end-user, and geographic region
  • Description of immunological compatibility, cargo capabilities and other intrinsic therapeutic activities of exosomes
  • Evaluation of exosome proteins and nucleic acids as diagnostic biomarkers and discussion of their impact on microRNA, liquid biopsy and stem cell research industry
  • Information on bioinformatics databases for exosome research and product development, including as ExoCarta, Vesiclopedia and EVpedia
  • Impact of exosome research on specific biopharmaceutical market and summary of details for major companies researching and producing exosome products
  • A relevant patent analysis on Exosome Diagnostics and Therapeutics in the U.S., Europe and Japan
  • Competitive landscape of the major players operating within global market, and their global rankings and company share analysis
  • Profile descriptions of the leading vendor companies including Codiak BioSciences, Evox Therapeutics, Exosome Diagnostics Inc., NonoSomiX Inc., and System Biosciences,

Report Scope

This report represents a current and important business tool to evaluate new commercial opportunities in the exosome diagnostic, therapeutic and research tool markets. The geographic scope of this study covers the U.S. and companies worldwide. This market is complex and consists of a number of different sectors, each affected differently by scientific and technological development. The report identifies the main positive and negative factors in each sector and forecasts further trends and product and assay development in every category of this industry.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Exosome Diagnostics and Therapeutics: Global Markets255 $5,500 Free
Chapter- 1: Introduction7Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market and Technology Background25$539Free
Chapter- 4: Impact of COVID-19 on the Exosome Therapeutics Market3$65Free
Chapter- 5: Exosome Diagnostics Market67$1,445Free
Chapter- 6: Exosome Therapeutics Market48$1,035Free
Chapter- 7: Exosome Reagents and Research Tools Market37$798Free
Chapter- 8: Global Exosome Therapeutic and Diagnostics Market by End User11$237Free
Chapter- 9: Global Exosome Therapeutic and Diagnostics Market by Region8$173Free
Chapter- 10: Impact of Exosome Research on Specific Biopharmaceutical Markets12$259Free
Chapter- 11: Patents and Pipeline Analysis19$410Free
Chapter- 12: Market Summary8$173Free
Chapter- 13: Company Profiles7$151Free
Published - Jun-2019| Analyst - Bhavna Joshi| Code - BIO149C

Report Highlights

The global market for exosome diagnostics and therapeutics should grow from $34.7 million in 2018 to $186.2 million by 2023, with a compound annual growth rate (CAGR) of 39.9% for the period of 2018-2023.

Report Includes

  • 106 tables
  • An overview of the global market for exosome diagnostics and therapeutics
  • Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Description of immunological compatibility, cargo capabilities and other intrinsic therapeutic activities of exosomes
  • Details of isolation and detection techniques and description of reagents and tools used for exosome research
  • Evaluation of exosomal proteins and nucleic acids as diagnostic biomarkers and discussion of their impact on microRNA, liquid biopsy and stem cell research industry
  • Information on bioinformatics databases for exosome research and product development, including as ExoCarta, Vesiclopedia and EVpedia
  • Company profiles of the prominent players, including Codiak BioSciences, Evox Therapeutics Ltd., Exosome Diagnostics Inc., HansaBioMed Life Sciences Ltd. (Lonza), NonoSomiX Inc., and System Biosciences (SBI)
Published - Jun-2018| Analyst - Marianna Tcherpakov| Code - BIO149B

Report Highlights

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

Report Includes

  • 35 data tables and 35 additional tables
  • An overview of the global markets and related technologies for exosome diagnostics and therapeutics
  • Analyses of global market trends, with data from 2016 to 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Breakdowns of new and existing diagnostic methods
  • Evaluations of current therapeutics and those likely to be utilized in the near future
  • Analyses of the market’s dynamics, specifically growth drivers, restraints, and opportunities
  • Company profiles of major players in the market, including Codiak BioSciences, Evox Therapeutics, Exosome Diagnostics, Inc., HansaBioMed, NonosomiX, Inc. and System Biosciences (SBI)
Published - Mar-2016| Analyst - Marianna Tcherpakov| Code - BIO149A

Report Highlights

The global market for exosome diagnostics and therapeutics is projected to grow from $16.1 million in 2016 to $111.8 million in 2021, a five-year compound annual growth rate (CAGR) of 47.3%.

Report Includes

  • An overview of the global markets and related technologies for exosome diagnostics and therapeutics.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
  • Breakdowns of new and exisiting diagnostic methods.
  • Evaluation of current therapeutics and those likely to be realized in the near future.
  • Analyses of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Profiles of major players in the industry.
Exosome Diagnostics and Therapeutics: Global Markets

Single User License: $5500

Member Price: FREE

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS